EGFR and non-small cell lung carcinoma: Mutations in the intracellular tyrosine kinase (TK) domain of EGFR have been reported in the pathogenesis of several human malignancies, including NSCLC (Hirsch and Bunn, 2009; Inamura et al., 2010).